3215 results for «2013»
3215 results
Late-Breaking Trial session
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the...
Basic imaging and procedural steps for T-TEER
08 Feb 2025 – From PCR Tokyo Valves 2025
Don’t miss this PCR Tokyo Valves 2025 session, where experts provide a comprehensive guide to T-TEER. Explore the basic anatomy and mechanisms essential for procedural planning and learn how to effectively image the tricuspid valve during T-TEER using 3D echocardiography and intracardiac echocardiogram. This session walks...
TAVI unplugged: multidisciplinary insights on roles and teamwork
08 Feb 2025 – From PCR Tokyo Valves 2025
Successful TAVI procedures rely on more than just technical expertise—they require seamless teamwork across specialties. In this session PCR Tokyo Valves 2025, discover the crucial roles of radiologists and nurses in the preoperative and intraoperative phases of TAVI. Through live case analysis and shared experiences, gain...
The 2025 top Japanese abstracts
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the latest cutting-edge research from Japan, as this session presents the top abstracts from 2025. Explore the impact of billowing on treatment outcomes in secondary mitral regurgitation, the mortality risk associated with severity of thinness in TAVR patients, the prognostic impact of delirium severity...
TAV-in-SAV - Part 1
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the complex world of TAV-in-SAV (Transcatheter Aortic Valve-in-Surgical Aortic Valve) in this comprehensive session. Explore various case studies, including valve-in-valve TAVI in a patient with structural valve deterioration, a successful case of balloon-assisted BASILICA for TAV-in-TAV, and TAVI after valve sparing aortic replacement. Gain...
TAVI access issues
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the challenges and innovative solutions surrounding TAVI access issues in this comprehensive session. Discover a one-step operation of transcarotid TAVI and PDA occlusion, a bailout case of transfemoral TAVI through a severely bent and calcified aorta, the role of transcaval access in hostile peripheral...
How to optimise the patient outcomes - Key considerations for the small body population
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest strategies for optimizing outcomes in Asian and international patients with small body size. Through case presentations, surgical experiences, and the latest data on device performance, gain valuable insights into treating aortic stenosis more effectively. Discover how these advancements can enhance patient care and...
Maximising the potential of MitraClip in TEER therapy
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest advancements in TEER therapy with this PCR Tokyo Valves 2025 session dedicated to MitraClip. Through expert-led case discussions, gain a deeper understanding of complex scenarios, including restricted posterior leaflet in functional mitral regurgitation, commissure lesion (A3P3), and MitraClip combined with Amulet.
This session also...
TAV-in-TAV cases
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this session to delve into the complexities and challenges of TAV-in-TAV procedures. Gain insights into various case studies, including a successful TAV-in-TAV with coronary protection, a case of CABG and TAV-in-TAV, TAVI in a patient with failed homograft and three previous sternotomies, and concurrent mitral...
M-TEER around the world
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in the field of Mitral Transcatheter Edge-to-Edge Repair (M-TEER) from around the world. Discover a new anatomical risk score for predicting procedural outcomes, two-year outcomes from the MiCLASP study, the impact of regurgitant volume to left atrial volume ratio on...
TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke
08 Feb 2025 – From PCR Tokyo Valves 2025
Gain valuable insights into the management of complications associated with Transcatheter Aortic Valve Implantation (TAVI). Discover the latest evidence on hemolytic anemia, the predictive value of the hemoglobin to creatinine ratio, outcomes of transcarotid TAVI, a case study on prosthetic valve endocarditis, the role of diastolic...
Hot topics in TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest hot topics in TAVI, including the impact of balloon-expandable TAVR valve deformation and calcium distribution on outcomes in bicuspid aortic valve, the outcomes of complex and high-risk vs. standard PCI in TAVI patients, hemodynamic outcomes after TAVI for aortic stenosis with small annuli,...
Valvular interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in valvular interventions in this comprehensive session. Dive into the medical cost analysis of TAVR versus SAVR in Japanese dialysis patients, the long-term outcomes of Myval valve implantation in the pulmonary position, the comparative effectiveness of balloon aortic valvuloplasty techniques,...
Bicuspid and complications
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this comprehensive session exploring the complexities of bicuspid aortic valve disease and the associated complications. Discover tailored sizing techniques for balloon-expandable valves in type 1 bicuspid, navigate the challenges of TAVR in bicuspid aortic valve type 0 with small annulus and coronary compromise, and...
Combined valve disease
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the management of combined valve disease, covering topics such as transcatheter tricuspid valve replacement and valve-in-valve/valve-in-ring implantation in high-risk patients, the importance of CT imaging analysis in predicting true mitral stenosis in TAVI patients, the clinical outcomes of mild-to-moderate mixed aortic valve...
TAVI in challenging anatomy
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the challenges of TAVI in complex anatomies, including cases of extremely horizontal aorta, extra-large aortic annulus with calcified amorphous tumour-like mass, severe atherosclerotic aorta complicated by severe aortic stenosis, transfemoral TAVI for severe aortic regurgitation with Stanford type B aortic dissection, and optimal TAVI...
TAVI complications cases - Part 1
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into the world of TAVI complications in this comprehensive session. Explore a range of challenging cases, including bailout implantation of an embolized self-expandable valve, ascending aortic dissection, coronary embolization, cardiac tamponade, and annular rupture. Gain insights into the management strategies and specialized techniques employed to...
Hotline TAVI 2: outcomes with new and established devices
21 May 2025 – From EuroPCR 2025
Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.
How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?
21 May 2025 – From EuroPCR 2025
Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.
Major Late-Breaking Trials from EuroPCR 2025
21 May 2025 – From EuroPCR 2025
Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...
